Sistema de Información Esencial en Terapéutica y Salud

@SIETES7

Última actualización: 5/8/2020
SIETES contiene 93082 citas

 
 
 1 a 20 de 39 siguiente >>
Presentar resultados
Seleccionar todas
1. Cita con resumen
Anónimo. Ferric carboxymaltose (Ferinject) for iron-deficiency anaemia. NPS Radar 2014:1. [Ref.ID 97755]
2.Tiene citas relacionadas Cita con resumen
Palmsten K, Hernández-Díaz S, Huybrechts KF, Williams PL, Michels KB, Achtyes ED, Mogun H, Setoguchi S. Use of antidepressants near delivery and risk of postpartum heaemorrhage: cohort study of low income women in the United States. BMJ 2013;347:10. [Ref.ID 96176]
3.Tiene citas relacionadas
Heerdink ER. Antidepressants and postpartum haemorrhage. BMJ 2013;347:8. [Ref.ID 96175]
4.
Elati A, Weeks A. Misoprostol for management of postpartum haemorrhage. BMJ 2011;343:330-1. [Ref.ID 91244]
5.Tiene citas relacionadas
Potts M, Prata N, Sahin-Hodoglugil NN. Misoprostol use in the community to reduce maternal death. Authors' reply. Lancet 2010;376:955-6. [Ref.ID 89370]
6.Tiene citas relacionadas
Gülmezoglu AM, Mathai M, Souza JP, d'Arcangues C, Mbizvo M. Misoprostol use in the community to reduce maternal death. Lancet 2010;376:955. [Ref.ID 89369]
7.Tiene citas relacionadas
Winikoff B, Blum J. Misoprostol use in the community to reduce maternal death. Lancet 2010;376:954-5. [Ref.ID 89368]
8.
Anónimo. Misoprostol for postpartum haemorrhage. Drug Ther Bull 2010;48:66-9. [Ref.ID 88616]
9.Tiene citas relacionadas
Potts M, Prata N, Sahin-Hodoglugil NN. Maternal mortality one death every 7 min. Lancet 2010;375:1762-3. [Ref.ID 88383]
10.Tiene citas relacionadas Cita con resumen
Weeks AD, Alia G, Vernon G, Namayanja A, Gosakan R, Majeed T, Hart A, Jafri H, Nardin J, Carroli G, Fairlie F, Raashid Y, Mirembe F, Alfirevic Z. Umbilical vein oxytocin for the treatment of retained placenta (Release Study): a double-blind, randomised controlled trial. Lancet 2010;375:141-7. [Ref.ID 87559]
11.Tiene citas relacionadas
Ekele B, Morhason-Bello I. Umbilical vein injection of oxytocin for retained placenta. Lancet 2010;375:98-9. [Ref.ID 87551]
12.
Miselli M. Carbetocina. Informazioni sui Farmaci 2009;33:5-7. [Ref.ID 85746]
13. Cita con resumen
Bergström S, Aronsson A. Misoprostol in resource poor countries. BMJ 2008;336:1032. [Ref.ID 82860]
14.
15.Tiene citas relacionadas Cita con resumen
Kongnyuy EJ, Wiysonge CS. Misoprostol and pregnancy termination. Lancet 2007;370:1824-5. [Ref.ID 81657]
16.Tiene citas relacionadas Cita con resumen
Hill S, Pang T. Leading by example: a culture change at WHO. Lancet 2007;369:1842-4. [Ref.ID 80185]
17. Cita con resumen
Costello A, Filippi V, Kubba T, Horton R. Research challenges to improve maternal and child survival. Lancet 2007;369:1240-3. [Ref.ID 79780]
18.Tiene citas relacionadas Cita con resumen
Weeks A. Oral misoprostol for postpartum haemorrhage. Lancet 2006;368:2123. [Ref.ID 78674]
19.
Spencer C, Murphy D, Bewley S. Caesarean delivery in the second stage of labour. BMJ 2006;333:613-4. [Ref.ID 78251]
20. Cita con resumen
Campbell OMR, Graham WJ, on behalf of The Lancet Maternal Survival Series steering group. Strategies for reducing maternal mortality: getting on with what works. Lancet 2006;368:1284-99. [Ref.ID 78143]
Seleccionar todas
 
 1 a 20 de 39 siguiente >>